j

Journal of gastrointestinal cancer

Journal of gastrointestinal cancer

Endoscopic submucosal dissection of early gastric cancer

Gastrointestinal cancer (GI cancer) is a term that refers to malignant tumors that start in the digestive system. Cancers of the esophagus, thyroid, liver, gall bladder, pancreas, small and large intestines, and anus are all included in GI cancer. 1 There is evidence to indicate that baseline HRQoL in colorectal,2-5 oesophageal,6 hepatocellular 7, and pancreatic 8 cancer predicts survival, as it does in many other cancers. HRQoL has been found to be a better indicator of prognosis than clinician-rated success status in the case of colorectal cancer. 2 and 3 At both the 2 year 9 and 10 year 10 follow-ups, psychotherapeutic help has been linked to improved survival rates for GI cancer patients.
Undernutrition and weight loss are common among GI cancer forms, owing to either local problems (e.g., dysphagia due to oesophageal obstruction) or other primary symptoms such as loss of appetite, taste abnormalities, early satiety, and exhaustion, which are collectively known as ‘cachexia.’ Undernutrition and cachexia have also been linked to a lower HRQoL and a worse prognosis. 11

Highlights asco gi 2020

Implementation of open peer review at the Editorial Office of the Journal of Gastrointestinal Oncology (JGO), Journal of Gastrointestinal Oncology

Promising results from the gastric cancer cohort of leap-005

Our editorial office has agreed to introduce a transparent peer review process as a choice for all manuscripts submitted to JGO beginning June 11, 2020, as part of our commitment to openness and accountability, as well as to increase the degree of transparency in our peer review process. Continue reading>>
Congratulations to the members of the Journal of Gastrointestinal Oncology’s Editorial Board!
Dr. Laura Dawson, Dr. Lisa Kachnic, and Dr. William Cance, all of whom are members of the editorial board of the Journal of Gastrointestinal Oncology, have been elected to new leadership positions at prominent organizations.
Continue reading>>
David A. Kooby, Bassel F. El-Rayes, Walter J. Curran Jr, William A. Hall, Lauren E. Colbert, Joseph W. Shelton, Shishir K. Maithel, Jerome Landry, David S. Yu, Jessica Cheng, Malcolm H. Squires III, John L. Mikell, Sarah B. Fisher, Charles A. Staley III, David A. Kooby, Bassel F. El-Rayes, Walter J. Cur

Trial updates at asco gi 2021

PubMed, PubMed Central, Science Citation Index Expanded (SCIE, also known as SciSearch®), Journal Citation Reports/Science Edition, Scopus, China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (CSTJ), and Superstar Journals Database have now abstracted and indexed the WJGO.
The 2019 impact factor (IF) for WJGO is 2.898 in the 2020 edition of Journal Citation Reports®; IF without journal self citations: 2.880; 5-year IF: 3.316; Ranking: 143 among 244 journals in oncology; Quartile category: Q3; Ranking: 55 among 88 journals in gastroenterology and hepatology; and Quartile category: Q3. The WJGO’s CiteScore for 2019 is 2.0, with a Scopus CiteScore rating of 86/137 in Gastroenterology.

Colorectal cancer: should dpd deficiency be searched

This section is dedicated to the study of tumorigenesis, prevention, early detection, and treatment of gastrointestinal tract neoplasias, with an emphasis on multidisciplinary studies to promote clinical applications of biological advances.
The Gastrointestinal Cancers segment aims to include a broad and systematic approach to tumorigenesis, prevention, early detection, and treatment of gastrointestinal tract neoplasia. Despite technical advances in endoscopy and imaging of GI Tract tumors, and their personalized therapies, knowledge of the molecular machinery causing and maintaining GI tract carcinogenesis, as well as the morphogenetic pathways leading to cancer, has only been partially translated to single patient care and population-based approaches.
The section’s ultimate goal is to promote multidisciplinary studies in order to accelerate the clinical application of biological advances. As a result, contributions on the following topics are particularly welcome in Gastrointestinal Cancers: